Advertisement
Advertisement
Tiziana Life Sciences Advances Nasal Foralumab Study for Multiple Sclerosis
PremiumCompany AnnouncementsTiziana Life Sciences Advances Nasal Foralumab Study for Multiple Sclerosis
20d ago
Tiziana Life Sciences Reports Interim Results and Expands U.S. Presence
Premium
Company Announcements
Tiziana Life Sciences Reports Interim Results and Expands U.S. Presence
1M ago
Tiziana Life Sciences to Attend Life Sciences Innovation Forum 2025 in Riyadh
Premium
Company Announcements
Tiziana Life Sciences to Attend Life Sciences Innovation Forum 2025 in Riyadh
2M ago
Tiziana Life Sciences Secures DoD Grant for Spinal Cord Injury Research
PremiumCompany AnnouncementsTiziana Life Sciences Secures DoD Grant for Spinal Cord Injury Research
2M ago
Tiziana Life Sciences announces U.S. DoD awarded research grant to study SCI
Premium
The Fly
Tiziana Life Sciences announces U.S. DoD awarded research grant to study SCI
2M ago
Tiziana Life Sciences CEO Increases Stake Amidst Ongoing Clinical Trials
Premium
Company Announcements
Tiziana Life Sciences CEO Increases Stake Amidst Ongoing Clinical Trials
2M ago
Tiziana Life Sciences announces purchase of shares by chairman
PremiumThe FlyTiziana Life Sciences announces purchase of shares by chairman
2M ago
Tiziana Life Sciences Initiates Phase 2a Trial for MSA with Intranasal Foralumab
Premium
Company Announcements
Tiziana Life Sciences Initiates Phase 2a Trial for MSA with Intranasal Foralumab
3M ago
Tiziana Life doses first patient in Phase 2a trial of intranasal foralumab
Premium
The Fly
Tiziana Life doses first patient in Phase 2a trial of intranasal foralumab
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100